Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)

Simple item page
dc.contributor.author Von Amsberg, Gunhild
dc.contributor.author Emmenegger, Urban
dc.contributor.author Robbrecht, Debbie G. J.
dc.contributor.author Arslan, Cagatay
dc.contributor.author Mehra, Niven
dc.contributor.author Gonzalez-Billalabeitia, Enrique
dc.contributor.author Yu, Evan Y.
dc.date.accessioned 2025-09-25T19:07:25Z
dc.date.available 2025-09-25T19:07:25Z
dc.date.issued 2025
dc.description.sponsorship Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA en_US
dc.description.sponsorship Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA en_US
dc.identifier.issn 1743-7555
dc.identifier.issn 1743-7563
dc.identifier.uri https://hdl.handle.net/20.500.14365/6470
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.relation.ispartof Asia-Pacific Journal of Clinical Oncology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.title Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC) en_US
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.wosid Gonzalez-Billalabeitia, Enrique/Abg-4621-2020
gdc.coar.access metadata only access
gdc.coar.type text::conference output
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Von Amsberg, Gunhild] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany; [Emmenegger, Urban] Sunnybrook Res Inst, Toronto, ON, Canada; [Robbrecht, Debbie G. J.] Erasmus MC Canc Inst, Rotterdam, Netherlands; [Arslan, Cagatay] Izmir Univ Econ, Medicalpoint Hosp, Izmir, Turkiye; [Mehra, Niven] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Gonzalez-Billalabeitia, Enrique] Hosp Univ 12 Octubre, Madrid, Spain; [Kwiatkowski, Mariusz] Szpital Wojewodzki Mikolaja Kopernika, Lodz, Poland; [Retz, Margitta] Tech Univ Munich, Rechts Isar Med Ctr, Munich, Germany; [Kose, Fatih] Baskent Univ, Adana Dr Turgut Noyan Applicat & Res Ctr, Adana, Turkiye; [Linch, Mark] UCL, UCL Hosp, London, England; [Linch, Mark] UCL Canc Inst, London, England; [Laguerre, Brigitte] Ctr Eugene Marquis, Rennes, France; [Mosca, Alessandra] IRCCS, Candiolo Canc Inst, FPO, Candiolo, Italy; [Limon, Juan Carlos Vazquez] Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico; [Vaena, Daniel] West Canc Ctr & Res Inst, Germantown, TN USA; [Wee, Christopher] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH USA; [Magallanes-Maciel, Manuel] Ctr Oncol Int, Jeddah, Saudi Arabia; [Hu, Haixia] MSD China Co Ltd, Shanghai, Peoples R China; [Schloss, Charles; Poehlein, Christian] Merck & Co Inc, Hoddesdon, England; [Yu, Evan Y.] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA en_US
gdc.description.endpage 119 en_US
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 119 en_US
gdc.description.volume 21 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q4
gdc.identifier.wos WOS:001552871000004
gdc.index.type WoS
gdc.virtual.author Arslan, Çağatay
gdc.wos.citedcount 0
relation.isAuthorOfPublication e39c1203-60be-410a-97b3-27cb69d126a9
relation.isAuthorOfPublication.latestForDiscovery e39c1203-60be-410a-97b3-27cb69d126a9
relation.isOrgUnitOfPublication 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd
relation.isOrgUnitOfPublication fbc53f3e-d1d3-4168-afd8-e42cd20bddd9
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection